Key result
Atrial biopsy may offer a new opportunity for the early detection of amyloid deposits, potentially improving clinical outcomes in cardiac amyloidosis.
Why the study?
Does atrial biopsy improve clinical outcomes in patients with early-stage cardiac amyloidosis?
Does atrial biopsy improve clinical outcomes in patients with early-stage cardiac amyloidosis?
Atrial biopsy is highlighted as a potential new opportunity for the early diagnosis of cardiac amyloidosis, which may improve clinical outcomes.
Early diagnosis of cardiac amyloidosis: potential role of atrial biopsy. Protein misfolding in the liver or bone marrow leads to amyloid fibril formation. The accumulation of these amyloid fibrils in the heart causes cardiac amyloidosis, increasing left atrial pressure and impairing left ventricular function. Early detection of amyloid deposits through an atrial biopsy (as shown by Shinzato et al.9) may improve clinical outcomes
No takes yet. Share an insight, caveat, or question.
Saljic et al. (2025) conducted an editorial in Cardiac amyloidosis. Atrial biopsy was evaluated. Atrial biopsy may offer a new opportunity for the early detection of amyloid deposits, potentially improving clinical outcomes in cardiac amyloidosis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: